rantes promoter
Recently Published Documents


TOTAL DOCUMENTS

34
(FIVE YEARS 0)

H-INDEX

18
(FIVE YEARS 0)

2014 ◽  
Vol 4 ◽  
pp. S10
Author(s):  
Ashok Kumar Jain ◽  
Arttrika Ranjan ◽  
Manish Kumar Tripathi ◽  
Jitendra Kumar Choudhary ◽  
Neha Singh ◽  
...  

2011 ◽  
Vol 20 (7) ◽  
pp. 1439-1446 ◽  
Author(s):  
Faten Charni ◽  
Angela Sutton ◽  
Pierre Rufat ◽  
Christelle Laguillier ◽  
Abdellah Mansouri ◽  
...  

2011 ◽  
Vol 54 ◽  
pp. S395
Author(s):  
F. Charni ◽  
A. Sutton ◽  
P. Rufat ◽  
J.-C. Trinchet ◽  
M. Beaugrand ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Irina P. Tereshchenko ◽  
Jana Petrkova ◽  
Mikhail I. Voevoda ◽  
Milos Taborsky ◽  
Zdenka Navratilova ◽  
...  

Coronary artery inflammation is a critical process in the pathogenesis of myocardial infarction (MI). The chemokine CCL5/RANTES (regulated upon activation, normal T cells expressed and secreted) is expressed in advanced atherosclerotic lesions. Functional polymorphisms of the RANTES gene can, therefore, be involved in the pathogenesis of coronary artery disease. We examined the association of polymorphisms in the RANTES gene with myocardial infarction in Slavonic populations of Czech and Russian origin. A total of 467 post-MI patients and 337 control subjects were genotyped for RANTES promoter G-403A (rs2107538) and intron 1.1 T/C (rs2280789) variants by PCR-SSP. Both RANTES genotypes and allele frequencies did not differ between case and control groups. Haplotype-based analysis also failed to reveal an association between MI and investigated markers. Strong linkage disequilibrium was detected between particular RANTES alleles. The data do not support an association between RANTES G-403A polymorphism and MI, as reported previously.


2010 ◽  
Vol 157 (6) ◽  
pp. 1038-1040.e1 ◽  
Author(s):  
Sonia Centi ◽  
Susanna Negrisolo ◽  
Alejandra Stefanic ◽  
Elisa Benetti ◽  
Walburga Cassar ◽  
...  

2009 ◽  
Vol 16 (6) ◽  
pp. 859-865 ◽  
Author(s):  
Tamaki Okabayashi ◽  
Shin-ichi Yokota ◽  
Yuko Yoto ◽  
Hiroyuki Tsutsumi ◽  
Nobuhiro Fujii

ABSTRACT Respiratory syncytial virus (RSV) infects airway epithelial cells, causing bronchiolitis and pneumonia. Inflammation is mediated by various cytokines secreted from RSV-infected airway epithelial cells, and it promotes the pathogenesis of RSV-related diseases. Fosfomycin (FOF) is approved as a treatment for various bacterial infectious diseases, including respiratory infectious diseases, in Japan. FOF is suggested to exhibit immunomodulatory effects on lipopolysaccharide-stimulated monocytes and T lymphocytes, in addition to its antimicrobial activity. We investigated the effect of FOF on the cytokine production of an airway epithelial cell line, A549, infected with RSV. RSV-induced cytokines, such as regulated on activation, normal T-cell expressed and secreted (RANTES), interleukin-8 (IL-8), and IL-6, in infected A549 cells. We found that FOF decreased the levels of RSV-induced RANTES and IL-8 but not the level of RSV-induced IL-6. The RANTES promoter was activated by RSV infection. Site-directed mutagenesis analysis of the RANTES promoter showed that NF-κB-binding motifs had a critical role in RSV-induced RANTES promoter activity. A luciferase reporter gene assay and a DNA-binding assay indicated that FOF suppressed the NF-κB activity induced by RSV infection. These results demonstrate that FOF treatment suppresses the RSV-induced transcription of the chemokines RANTES and IL-8 in airway epithelial cells.


2009 ◽  
Vol 60 (4) ◽  
pp. 1173-1178 ◽  
Author(s):  
Tsung-Chieh Yao ◽  
Yi-Chan Tsai ◽  
Jing-Long Huang

2009 ◽  
Vol 45 (2) ◽  
pp. 235-240 ◽  
Author(s):  
Tomomitsu Tahara ◽  
Tomoyuki Shibata ◽  
Hiromi Yamashita ◽  
Ichiro Hirata ◽  
Tomiyasu Arisawa

Sign in / Sign up

Export Citation Format

Share Document